ASCET.
| Trial name or title | ASpirin non‐responsiveness and Clopidogrel Endpoint Trial (ASCET) |
| Methods | Randomised, open label |
| Participants | 1000 patients with documented coronary heart disease |
| Interventions | Continued treatment with aspirin 160 mg daily versus or change to clopidogrel 75 mg daily |
| Outcomes | Composite of unstable angina, myocardial infarction, stroke or death |
| Starting date | April 2003 |
| Contact information | http://clinicaltrials.gov/ct2/show/NCT00222261 |
| Notes |